HDAC9 and lymphoma: As proof of concept, a cell line derived from a lung transplant recipient’s EBV-associated lymphoma was exposed to arginine butyrate, a histone deacetylase (HDAC) inhibitor, resulting in induction of EBV TK transcription, and culture in the presence of ganciclovir resulted in cell cycle arrest and cell death[77].